{"id":100162,"date":"2012-04-03T02:06:34","date_gmt":"2012-04-03T02:06:34","guid":{"rendered":"https:\/\/knome.com\/?p=100162"},"modified":"2024-09-12T13:36:06","modified_gmt":"2024-09-12T13:36:06","slug":"knome-selected-as-a-genome-interpretation-partner-for-illumina-genome-network","status":"publish","type":"post","link":"https:\/\/www.knome.com\/?p=100162","title":{"rendered":"Knome Selected as a Genome Interpretation Partner for Illumina Genome Network"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; _builder_version=&#8221;4.27.0&#8243; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_row admin_label=&#8221;row&#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_heading title=&#8221;Knome Selected as a Genome Interpretation Partner for Illumina Genome Network&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; title_text_color=&#8221;#E02B20&#8243; title_font_size=&#8221;25px&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_heading][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; text_font_size=&#8221;14px&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg\" width=\"249\" height=\"250\" alt=\"\" class=\"wp-image-100163 alignnone size-full\" style=\"float: left;\" srcset=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg 249w, https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg-150x150.jpg 150w\" sizes=\"(max-width: 249px) 100vw, 249px\" \/>Firms partner to offer Illumina\u2019s high-quality genome sequencing services in combination with Knome\u2019s advanced genome interpretation solutions<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>CAMBRIDGE, MA \u2013 April 3, 2012 \u2013 Knome Inc., the human genome interpretation company, announced today that it has been selected by Illumina, Inc., (NASDAQ: ILMN) as a partner in the Illumina Genome Network (IGN). As part of the agreement, IGN customers will have access to preferential pricing for Knome\u2019s genome interpretation tools and services. The agreement also calls for the companies to further integrate their data pipelines in order to provide end users with accelerated turnaround times.<\/p>\n<p>\u201cKnome\u2019s software tools and services, knomeBASE and knomeDISCOVERY, are well positioned to help address the needs of Illumina\u2019s customers,\u201d said Scott Kahn, Vice President and Chief Information Officer at Illumina. \u201cIGN will provide fully processed and summarized genomic information from its whole genome and cancer analysis services directly to Knome, which will use the data to deliver subsequent interpretations. These reports include comprehensive annotation and interactive analyses that are very attractive to users with little or no in-house bioinformatics expertise, and to those who want to perform multi-sample analysis.\u201d<\/p>\n<p>\u201cWe have often worked together on a case-by-case basis to provide researchers with a complete sequencing and interpretation solution\u2014the most recent example being the landmark 1,000 genomes asthma study by Johns Hopkins University School of Medicine,\u201d said Ari Kiirikki, Knome\u2019s Vice President of Business Development. \u201cNow that we have entered into a formal partnership, we look forward to working together to proactively identify researchers, drug developers, and clinics with interpretation bottlenecks in order to deliver a seamless end-to-end solution.\u201d<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;13px&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><strong>About Knome<\/strong><br \/><span>Knome is a life sciences company that specializes in the interpretation of human genomes. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. In 2008, Knome had the distinction of being the first company to interpret a human whole genome for a commercial client. Since then, Knome has worked on over 100 interpretation projects in more than two dozen countries.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Firms partner to offer Illumina\u2019s high-quality genome sequencing services in combination with Knome\u2019s advanced genome interpretation solutions &nbsp; CAMBRIDGE, MA \u2013 April 3, 2012 \u2013 Knome Inc., the human genome interpretation company, announced today that it has been selected by Illumina, Inc., (NASDAQ: ILMN) as a partner in the Illumina Genome Network (IGN). As part [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":100163,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<img class=\"size-full wp-image-100015 alignleft\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/GENALICE.jpg\" alt=\"\" width=\"300\" height=\"70\" \/>\r\n\r\nHARDERWIJK, the Netherlands and CAMBRIDGE, Mass \u2013 January 12, 2015 \u2013 Today GENALICE and Knome, Inc. USA jointly announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret patients\u2019 genomes. GENALICE MAP is an ultra-fast and highly accurate preprocessing solution for aligning and calling NGS data and seamlessly connects to Knome\u2019s informatics and genomics interpretation system, the knoSYS<sup>\u00ae<\/sup>\u00a0platform.\r\n\r\nStated CEO and President of Knome, Wolfgang Daum, \u201cThe GENALICE and Knome partnership came about in response to the reality that the amount of NGS data and its increasing usage requires processing and interpreting at an incredible pace. Wide-spread implementation of sequencing in the clinic toward the goal of precision medicine will only make this fact more apparent.\u201d\r\n\r\nWhile both products will continue to be offered separately, customers wanting to take advantage of the combined system can expect a reduction of NGS data bottlenecks, improved ability to annotate and interpret human genomes, and unprecedented control over their data from end-to-end.\r\n\r\nHans Karten, CEO of GENALICE, commented, \u201cWhereas GENALICE MAP speeds up and improves the process of aligning and calling genomes, the knoSYS platform focuses on the annotation and interpretation piece. These two products complement each other beautifully in creating a workflow that eliminates many of the frustrations of wrangling NGS data today.\u201d\r\n\r\n<strong>About Knome, Inc.<\/strong>\r\nKnome, Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. Designed to accelerate and industrialize the process of interpreting whole genomes, Knome\u2019s big data technologies are helping to smooth the healthcare industry\u2019s transition to molecular-based, precision medicine.\r\n\r\n<strong>About GENALICE<\/strong>\r\nGENALICE is a highly innovative biomedical big data company, with global headquarters in the Netherlands. GENALICE designs and builds groundbreaking software solutions for ultra-fast, highly accurate and cost-effective DNA data processing and analysis on general-purpose hardware. With GENALICE MAP, it introduced the first Next-Generation Sequencing (NGS) data processing pipeline with true population power. By partnering with world-renowned research institutes and healthcare companies, GENALICE is committed to unlocking the potential of whole genome and exome sequencing for biomarker discovery and medical application. More information on GENALICE can be found at\u00a0<a href=\"http:\/\/www.genalice.com\/\" target=\"_blank\" rel=\"noopener\">www.genalice.com<\/a>.\r\n\r\n<strong>Media Contacts<\/strong>\r\n<div>Knome, Inc. USA\r\nJessica Vionas\r\nDirector of Marketing\r\n617-715-1000 x2012\r\njvionas@knome.com<\/div>\r\n<div>GENALICE B.V.\r\nJos Lunenberg\r\nChief Business Officer\r\n+31 88 1221 000\r\njos.lunenberg@genalice.com<\/div>\r\n<p align=\"center\">###<\/p>\r\n<p align=\"center\"><\/p>","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-100162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Knome: A Genome Interpretation Partner for Illumina Genome Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.knome.com\/?p=100162\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Knome: A Genome Interpretation Partner for Illumina Genome Network\" \/>\n<meta property=\"og:description\" content=\"Firms partner to offer Illumina\u2019s high-quality genome sequencing services in combination with Knome\u2019s advanced genome interpretation solutions &nbsp; CAMBRIDGE, MA \u2013 April 3, 2012 \u2013 Knome Inc., the human genome interpretation company, announced today that it has been selected by Illumina, Inc., (NASDAQ: ILMN) as a partner in the Illumina Genome Network (IGN). As part [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.knome.com\/?p=100162\" \/>\n<meta property=\"og:site_name\" content=\"Knome | Genome Interpretation Systems &amp; Services\" \/>\n<meta property=\"article:published_time\" content=\"2012-04-03T02:06:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-12T13:36:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"249\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jason Bailey\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jason Bailey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162\"},\"author\":{\"name\":\"Jason Bailey\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\"},\"headline\":\"Knome Selected as a Genome Interpretation Partner for Illumina Genome Network\",\"datePublished\":\"2012-04-03T02:06:34+00:00\",\"dateModified\":\"2024-09-12T13:36:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162\"},\"wordCount\":554,\"image\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162\",\"url\":\"https:\\\/\\\/www.knome.com\\\/?p=100162\",\"name\":\"Knome: A Genome Interpretation Partner for Illumina Genome Network\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg\",\"datePublished\":\"2012-04-03T02:06:34+00:00\",\"dateModified\":\"2024-09-12T13:36:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.knome.com\\\/?p=100162\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162#primaryimage\",\"url\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg\",\"contentUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg\",\"width\":249,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100162#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.knome.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Knome Selected as a Genome Interpretation Partner for Illumina Genome Network\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#website\",\"url\":\"https:\\\/\\\/www.knome.com\\\/\",\"name\":\"Knome | Genome Interpretation Systems &amp; Services\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.knome.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\",\"name\":\"Jason Bailey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"caption\":\"Jason Bailey\"},\"url\":\"https:\\\/\\\/www.knome.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Knome: A Genome Interpretation Partner for Illumina Genome Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.knome.com\/?p=100162","og_locale":"en_US","og_type":"article","og_title":"Knome: A Genome Interpretation Partner for Illumina Genome Network","og_description":"Firms partner to offer Illumina\u2019s high-quality genome sequencing services in combination with Knome\u2019s advanced genome interpretation solutions &nbsp; CAMBRIDGE, MA \u2013 April 3, 2012 \u2013 Knome Inc., the human genome interpretation company, announced today that it has been selected by Illumina, Inc., (NASDAQ: ILMN) as a partner in the Illumina Genome Network (IGN). As part [&hellip;]","og_url":"https:\/\/www.knome.com\/?p=100162","og_site_name":"Knome | Genome Interpretation Systems &amp; Services","article_published_time":"2012-04-03T02:06:34+00:00","article_modified_time":"2024-09-12T13:36:06+00:00","og_image":[{"width":249,"height":250,"url":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg","type":"image\/jpeg"}],"author":"Jason Bailey","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jason Bailey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.knome.com\/?p=100162#article","isPartOf":{"@id":"https:\/\/www.knome.com\/?p=100162"},"author":{"name":"Jason Bailey","@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3"},"headline":"Knome Selected as a Genome Interpretation Partner for Illumina Genome Network","datePublished":"2012-04-03T02:06:34+00:00","dateModified":"2024-09-12T13:36:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.knome.com\/?p=100162"},"wordCount":554,"image":{"@id":"https:\/\/www.knome.com\/?p=100162#primaryimage"},"thumbnailUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.knome.com\/?p=100162","url":"https:\/\/www.knome.com\/?p=100162","name":"Knome: A Genome Interpretation Partner for Illumina Genome Network","isPartOf":{"@id":"https:\/\/www.knome.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.knome.com\/?p=100162#primaryimage"},"image":{"@id":"https:\/\/www.knome.com\/?p=100162#primaryimage"},"thumbnailUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg","datePublished":"2012-04-03T02:06:34+00:00","dateModified":"2024-09-12T13:36:06+00:00","author":{"@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3"},"breadcrumb":{"@id":"https:\/\/www.knome.com\/?p=100162#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.knome.com\/?p=100162"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.knome.com\/?p=100162#primaryimage","url":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg","contentUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/IllumaFeature-2we28b67wukmz1007h2qkg.jpg","width":249,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/www.knome.com\/?p=100162#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.knome.com\/"},{"@type":"ListItem","position":2,"name":"Knome Selected as a Genome Interpretation Partner for Illumina Genome Network"}]},{"@type":"WebSite","@id":"https:\/\/www.knome.com\/#website","url":"https:\/\/www.knome.com\/","name":"Knome | Genome Interpretation Systems &amp; Services","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.knome.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3","name":"Jason Bailey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","url":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","caption":"Jason Bailey"},"url":"https:\/\/www.knome.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=100162"}],"version-history":[{"count":3,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100162\/revisions"}],"predecessor-version":[{"id":100166,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100162\/revisions\/100166"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/media\/100163"}],"wp:attachment":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=100162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=100162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=100162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}